133 related articles for article (PubMed ID: 8126264)
1. Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG.
Mogard J; Kihlström L; Ericson K; Karlsson B; Guo WY; Stone-Elander S
J Comput Assist Tomogr; 1994; 18(2):177-81. PubMed ID: 8126264
[TBL] [Abstract][Full Text] [Related]
2. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography using 18F-fluorodeoxyglucose in patients with stereotactically irradiated brain metastases.
Ericson K; Kihlström L; Mogard J; Karlsson B; Lindquist C; Widén L; Collins VP; Stone-Elander S
Stereotact Funct Neurosurg; 1996; 66 Suppl 1():214-24. PubMed ID: 9032864
[TBL] [Abstract][Full Text] [Related]
4. Although Non-diagnostic Between Necrosis and Recurrence, FDG PET/CT Assists Management of Brain Tumours After Radiosurgery.
Torrens M; Malamitsi J; Karaiskos P; Valotassiou V; Laspas F; Andreou J; Stergiou C; Prassopoulos V
In Vivo; 2016; 30(4):513-20. PubMed ID: 27381617
[TBL] [Abstract][Full Text] [Related]
5. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
[TBL] [Abstract][Full Text] [Related]
7. FDG PET/MRI Coregistration Helps Predict Response to Gamma Knife Radiosurgery in Patients With Brain Metastases.
Leiva-Salinas C; Muttikkal TJE; Flors L; Puig J; Wintermark M; Patrie JT; Rehm PK; Sheehan JP; Schiff D
AJR Am J Roentgenol; 2019 Feb; 212(2):425-430. PubMed ID: 30422717
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography.
Doyle WK; Budinger TF; Valk PE; Levin VA; Gutin PH
J Comput Assist Tomogr; 1987; 11(4):563-70. PubMed ID: 3496366
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
[TBL] [Abstract][Full Text] [Related]
11. PET-FDG of pleomorphic xanthoastrocytoma.
Bicik I; Raman R; Knightly JJ; Di Chiro G; Fulham MJ
J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091
[TBL] [Abstract][Full Text] [Related]
12. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK
Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831
[TBL] [Abstract][Full Text] [Related]
13. Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma.
Deshmukh A; Scott JA; Palmer EL; Hochberg FH; Gruber M; Fischman AJ
Clin Nucl Med; 1996 Sep; 21(9):720-5. PubMed ID: 8879874
[TBL] [Abstract][Full Text] [Related]
14. Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
Ceccon G; Lohmann P; Stoffels G; Judov N; Filss CP; Rapp M; Bauer E; Hamisch C; Ruge MI; Kocher M; Kuchelmeister K; Sellhaus B; Sabel M; Fink GR; Shah NJ; Langen KJ; Galldiks N
Neuro Oncol; 2017 Feb; 19(2):281-288. PubMed ID: 27471107
[TBL] [Abstract][Full Text] [Related]
15. Glucose consumption in recurrent gliomas.
Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S
Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844
[TBL] [Abstract][Full Text] [Related]
16. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma.
Fischman AJ; Thornton AF; Frosch MP; Swearinger B; Gonzalez RG; Alpert NM
J Nucl Med; 1997 Jul; 38(7):1027-9. PubMed ID: 9225785
[TBL] [Abstract][Full Text] [Related]
17. Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study.
Maruyama I; Sadato N; Waki A; Tsuchida T; Yoshida M; Fujibayashi Y; Ishii Y; Kubota T; Yonekura Y
J Nucl Med; 1999 Jul; 40(7):1085-90. PubMed ID: 10405124
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer.
Greven KM; Williams DW; Keyes JW; McGuirt WF; Harkness BA; Watson NE; Raben M; Frazier LC; Geisinger KR; Cappellari JO
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):841-5. PubMed ID: 8040032
[TBL] [Abstract][Full Text] [Related]
19. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
[TBL] [Abstract][Full Text] [Related]
20. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
